- Home
- AUPH vs INDV Comparison
AUPH vs INDV Comparison
Compare AUPH & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- INDV
- Stock Information
- Founded
- AUPH 1993
- INDV 1994
- Country
- AUPH Canada
- INDV United States
- Employees
- AUPH N/A
- INDV N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- AUPH Health Care
- INDV Health Care
- Exchange
- AUPH Nasdaq
- INDV Nasdaq
- Market Cap
- AUPH 1.1B
- INDV 1.9B
- IPO Year
- AUPH 1999
- INDV N/A
- Fundamental
- Price
- AUPH $8.96
- INDV $15.39
- Analyst Decision
- AUPH Strong Buy
- INDV Strong Buy
- Analyst Count
- AUPH 2
- INDV 2
- Target Price
- AUPH $11.50
- INDV $17.50
- AVG Volume (30 Days)
- AUPH 2.0M
- INDV 2.2M
- Earning Date
- AUPH 07-31-2025
- INDV 07-28-2025
- Dividend Yield
- AUPH N/A
- INDV N/A
- EPS Growth
- AUPH N/A
- INDV N/A
- EPS
- AUPH 0.27
- INDV N/A
- Revenue
- AUPH $247,295,000.00
- INDV $1,170,000,000.00
- Revenue This Year
- AUPH $12.15
- INDV N/A
- Revenue Next Year
- AUPH $18.34
- INDV $3.00
- P/E Ratio
- AUPH $33.62
- INDV N/A
- Revenue Growth
- AUPH 29.20
- INDV 4.09
- 52 Week Low
- AUPH $5.20
- INDV $7.33
- 52 Week High
- AUPH $10.67
- INDV $15.91
- Technical
- Relative Strength Index (RSI)
- AUPH 63.15
- INDV 71.25
- Support Level
- AUPH $8.73
- INDV $14.93
- Resistance Level
- AUPH $9.10
- INDV $15.91
- Average True Range (ATR)
- AUPH 0.44
- INDV 0.47
- MACD
- AUPH 0.13
- INDV 0.00
- Stochastic Oscillator
- AUPH 92.56
- INDV 86.76
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.